Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1000275 TORONTO, A6
Back to TMO Full portfolio

Position in TMO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,923,800,734
-$415,002,003 QoQ
Shares Held
3,913,903
-3.0% QoQ
Ownership
1.05%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 97.79608743497221.ToString("F0")% Shared 1.949690628510722.ToString("F0")% None 0.2542219365170777.ToString("F0")%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Derivatives in TMO

reported options exposure · as of Mar 31, 2026
CallValue
$3,686,475
CallShares
7,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

ROYAL BANK OF CANADA holds $3,593,465,193 across 39 Diagnostics & Research names. TMO ranks #1 (53.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
This page 		3,913,903 $1,923,800,734
2 DHR
Danaher Corp /De/
 3,299,528 $625,590,502
3 IDXX
Idexx Laboratories Inc /De
 391,704 $220,094,556
4 LH
Labcorp Holdings Inc.
 820,442 $218,902,126
5 A
Agilent Technologies, Inc.
 828,773 $94,463,542
6 IQV
Iqvia Holdings Inc.
 401,428 $68,459,527
7 WAT
Waters Corp /De/
 228,857 $68,153,609
8 MEDP
Medpace Holdings, Inc.
 123,929 $59,509,461

All Filings in TMO

Export CSV
42 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,923,800,734 3,913,903
2026-03-31 $3,686,475 7,500
2025-12-31 $2,338,802,737 4,036,246
2025-12-31 $4,345,875 7,500
2025-09-30 $1,320,578,014 2,722,729
2025-06-30 $30,409,500 75,000
2025-06-30 $1,344,567,793 3,316,154
2025-03-31 $1,604,598,772 3,224,676
2024-12-31 $1,702,468,793 3,272,531
2024-09-30 $2,008,029,141 3,246,244
2024-09-30 $50,722,740 82,000
2024-06-30 $1,812,616,211 3,277,787
2024-03-31 $1,849,971,080 3,182,965
2023-12-31 $1,722,080,735 3,244,373
2023-12-31 $17,038,359 32,100
2023-09-30 $2,326,083,472 4,595,459
2023-09-30 $5,314,785 10,500
2023-09-30 $16,248,057 32,100
2023-06-30 $2,465,987,192 4,726,377
2023-06-30 $16,748,175 32,100
2023-03-31 $6,051,885 10,500
2023-03-31 $28,242,130 49,000
2023-03-31 $1,669,787,686 2,897,076
2022-12-31 $1,478,255,706 2,684,370
2022-12-31 $16,520,700 30,000
2022-09-30 $15,215,700 30,000
2022-09-30 $1,288,577,557 2,540,621
2022-06-30 $1,283,262,667 2,362,065
2022-03-31 $5,020,525 8,500
2022-03-31 $1,465,660,165 2,481,436
2021-12-31 $1,671,832,531 2,505,594
2021-09-30 $1,402,112,371 2,454,120
2021-06-30 $3,228,608 6,400
2021-06-30 $1,287,530,016 2,552,243
2021-03-31 $1,171,524,712 2,566,994
2020-12-31 $1,134,988,011 2,436,747
2020-12-31 $15,324,162 32,900
2020-12-31 $15,603,630 33,500
2020-09-30 $3,090,640 7,000
2020-09-30 $1,133,500,163 2,567,268
2020-06-30 $868,159,387 2,395,980
2020-03-31 $654,711,578 2,308,574

Report a Problem

Category
Description
Email (optional, for follow-up)